Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Rosser EJ. Causes of otitis externa. Vet Clin North Am Small Anim Pract 2004;34: 459–468.
-
2
Griffin CE. Otitis externa and otitis media. In:Griffin CE, Kwochka KW, MacDonald JM, eds.Current veterinary dermatology. St Louis: Mosby Year Book Inc, 1993;244–262.
-
3
Spreull JSA. Treatment of otitis media in the dog. J Small Anim Pract 1964;5: 107–152.
-
4
Cole LK, Kwochka KW & Podell M, et al. Evaluation of radiography, otoscopy, pneumotoscopy, impedance audiometry and endoscopy for the diagnosis of otitis media. In:Thoday KL, Foil KL, Bond R. eds.Advances in veterinary dermatology. Vol 4. Oxford, England: Blackwell Publishing Ltd, 2002;49–55.
-
5
Blue JL, Wooley RE. Antibacterial sensitivity patterns of bacteria isolated from dogs with otitis externa. J Am Vet Med Assoc 1977;171: 362–363.
-
6
Kowalski JJ. The microbial environment of the ear canal in health and disease. Vet Clin North Am Small Anim Pract 1988;18: 743–754.
-
7
Marshall MJ, Harris AM, Horne JE. The bacteriological and clinical assessment of a new preparation for the treatment of otitis externa in dogs and cats. J Small Anim Pract 1983;24: 413–421.
-
8
McCarthy G, Kelly WR. Microbial species associated with the canine ear and their antibacterial sensitivity patterns. Ir Vet J 1982;36: 53–56.
-
9
Nesbitt GH, Schnitz JA. Chronic bacterial dermatitis and otitis: a review of 195 cases. J Am Anim Hosp Assoc 1977;13: 442–450.
-
10
Sharma VD, Rhoades HE. The occurrence and microbiology of otitis externa in the dog. J Small Anim Pract 1975;16: 241–247.
-
11
Colombini S, Merchant SR, Hosgood G. Microbial flora and antimicrobial susceptibility patterns from dogs with otitis media. Vet Dermatol 2000;11: 235–239.
-
12
Roberts NA, Gray GW, Wilkinson SC. The bactericidal action of ethylenediaminetetra-acetic acid on Pseudomonas aeruginosa. Microbios 1970;7–8:189–208.
-
13
Goldschmidt MC, Wyss O. The role of Tris in EDTA toxicity and lysozyme lysis. J Gen Microbiol 1967;47: 421–431.
-
14
Leive L. A nonspecific increase in permeability in Escherichia coli produced by EDTA. Proc Natl Acad Sci U S A 1965;53: 745–750.
-
15
Brown MRW, Richards RME. Effect of ethylenediamine tetraacetate on the resistance of Pseudomonas aeruginosa to antibacterial agents. Nature 1965;207: 1391–1393.
-
16
Russel AD. Effect of magnesium ions and ethylenediamine tetra-acetic acid on the activity of vancomycin against Escherichia coli and Staphylococcus aureus. J Appl Bacteriol 1967;30: 395–401.
-
17
Wooley RE, Jones MS. Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria. Vet Microbiol 1983;8: 271–280.
-
18
Leive L, Shovlin VK, Mergenhagen SE. Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem 1968;243: 6384–6391.
-
19
Sparks TA, Kemp DT & Wooley RE, et al. Antimicrobial effect of combinations of EDTA-Tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs. Vet Res Commun 1994;18: 241–249.
-
20
Wooley RE, Jones MS & Gilbert JP, et al. In vitro action of combinations of antimicrobial agents and EDTA-tromethamine on Pseudomonas aeruginosa. Am J Vet Res 1983;44: 1521–1524.
-
21
Wooley RE, Jones MS & Gilbert JP, et al. In vitro effect of combinations of antimicrobial agents and EDTA-tromethamine on certain gram-positive bacteria. Am J Vet Res 1983;44: 2167–2169.
-
22
Farca AM, Nebbia P, Re G. Potentiation of the in vitro activity of some antimicrobial agents against selected gram-negative bacteria by EDTA-tromethamine. Vet Res Commun 1993;17: 77–84.
-
23
Farca AM, Nebbia P, Re G. Potentiation of antibiotic activity by EDTA-tromethamine against three clinically isolated gram-positive resistant bacteria. An in vitro investigation. Vet Res Commun 1994;18: 1–6.
-
24
Harvey SC. Antiseptics and disinfectants; fungicides; ectoparasiticides. In:Gilman AG, Goodman LS, Rall TW, et al, eds.The pharmacological basis of therapeutics. 7th ed.New York: MacMillan Publishing Co, 1985;959–979.
-
25
Karabit MS, Juneskans OT, Lundgren P. Studies on the evaluation of preservative efficacy-II. The determination of antimicrobial characteristics of benzyl alcohol. J Clin Hosp Pharm 1986;11: 281–289.
-
26
Antimicrobial effectiveness testing. In:The United States pharmacopeia. 28th ed.Rockville, Md: The United States Pharmacopeia Inc, 2005;2242–2243.
-
27
Microbial limits test. In:The United States pharmacopeia. 28th ed.Rockville, Md: The United States Pharmacopeia Inc, 2005;2246–2251.
-
28
Wooley RE, Blue JL. In vitro effect of EDTA-tris-lysozyme solutions on selected pathogenic bacteria. J Med Microbiol 1975;8: 189–194.
-
29
Wooley RE, Dickerson HW, Engen WR. Treating canine otitis externa with an EDTA-TRIS-SDS combination. Vet Med 1988;83: 1088–1091.
-
30
Cutinelli C, Galdiero F. Ion-binding properties of the cell wall of Staphylococcus aureus. J Bacteriol 1967;93: 2022–2023.
-
31
Cutinelli C, Wooley RE. Gram-positive pyogenic bacteria. In:Ofek I, Doyle RJ, eds.Bacterial adhesion to cells and tissues. New York: Chapman & Hall, 1994;136–170.
-
32
Farca AM, Piromalli G & Maffei F, et al. Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis, and cystitis. 1997;38:243–245.
Advertisement
In vitro activity of an ear rinse containing tromethamine, EDTA, and benzyl alcohol on bacterial pathogens from dogs with otitis
Abstract
Objective—To evaluate the in vitro activity of an ear rinse (ER) containing tromethamine, EDTA, and benzyl alcohol on bacterial pathogens from dogs with otitis.
Sample Population—Organisms were collected from ear swab specimens from the external and middle ear and included Staphylococcus spp (n = 11; Staphylococcus intermedius [7] and Staphylococcus spp [4]), Pseudomonas aeruginosa (5), Proteus spp (5), β-hemolytic streptococcus (11), and 1 control strain of each organism.
Procedures—3 test solutions were evaluated including EDTA, tromethamine, and benzyl alcohol (ER); EDTA and tromethamine (ER without benzyl alcohol [ER – BA]); and purified water. Ten-milliliter aliquots of each test solution were transferred into 36 tubes and inoculated with one of the organisms. Samples were retrieved from each tube at 0, 15, 30, 45, and 60 minutes, transferred to Petri dishes, mixed with soybeancasein digest agar, and incubated. After incubation, plates were examined for growth, and the number of colonies was expressed as CFU per milliliter.
Results—ER significantly decreased bacterial growth in vitro of P aeruginosa and β-hemolytic streptococcal organisms within 15 minutes, Proteus spp within 30 minutes, and Staphylococcus spp within 60 minutes. Comparatively, the presence of benzyl alcohol in ER significantly decreased bacterial growth of β-hemolytic streptococcus and Proteus spp.
Conclusions and Clinical Relevance—On the basis of results of this study, future studies should be performed to evaluate the in vivo efficacy of ER alone as a treatment for otic infections caused by β-hemolytic streptococcus, P aeruginosa, and Proteus spp and of ER combined with an antimicrobial agent for otic infections caused by Staphylococcus spp.
Contributor Notes
Supported by IVX Animal Health Incorporated.
Presented in part at the 20th Annual Meeting of the North American Veterinary Dermatology Forum, Sarasota, Fla, April 2005.
Powered by PubFactory